1.Brain site-specific proteome changes in aging-related dementia.
Arulmani MANAVALAN ; Manisha MISHRA ; Lin FENG ; Siu Kwan SZE ; Hiroyasu AKATSU ; Klaus HEESE
Experimental & Molecular Medicine 2013;45(9):e39-
This study is aimed at gaining insights into the brain site-specific proteomic senescence signature while comparing physiologically aged brains with aging-related dementia brains (for example, Alzheimer's disease (AD)). Our study of proteomic differences within the hippocampus (Hp), parietal cortex (pCx) and cerebellum (Cb) could provide conceptual insights into the molecular mechanisms involved in aging-related neurodegeneration. Using an isobaric tag for relative and absolute quantitation (iTRAQ)-based two-dimensional liquid chromatography coupled with tandem mass spectrometry (2D-LC-MS/MS) brain site-specific proteomic strategy, we identified 950 proteins in the Hp, pCx and Cb of AD brains. Of these proteins, 31 were significantly altered. Most of the differentially regulated proteins are involved in molecular transport, nervous system development, synaptic plasticity and apoptosis. Particularly, proteins such as Gelsolin (GSN), Tenascin-R (TNR) and AHNAK could potentially act as novel biomarkers of aging-related neurodegeneration. Importantly, our Ingenuity Pathway Analysis (IPA)-based network analysis further revealed ubiquitin C (UBC) as a pivotal protein to interact with diverse AD-associated pathophysiological molecular factors and suggests the reduced ubiquitin proteasome degradation system (UPS) as one of the causative factors of AD.
Aged, 80 and over
;
Alzheimer Disease/*metabolism
;
Brain/*metabolism
;
Female
;
Gelsolin/genetics/metabolism
;
Humans
;
Male
;
Membrane Proteins/genetics/metabolism
;
Neoplasm Proteins/genetics/metabolism
;
Organ Specificity
;
Proteome/genetics/*metabolism
;
Tenascin/genetics/metabolism
;
Ubiquitin C/genetics/metabolism
2.Effect and mechanism of Danggui Buxue Decoction-containing serum in mitigating H9c2 cell injury caused by exposure to intermittent low oxygen.
Ting-Ting LI ; Jie CHEN ; En-Sheng JI ; Ya-Jing GUO
China Journal of Chinese Materia Medica 2023;48(21):5881-5887
This study aims to explore the effect and mechanism of Danggui Buxue Decoction(DBD)-containing serum in alleviating the H9c2 cell injury caused by the exposure to intermittent low oxygen. H9c2 cells were assigned into five groups: control(CON) group, intermittent low oxygen(IH) group, intermittent low oxygen plus DBD-containing serum(IH+DBD) group, intermittent low oxygen plus the autophagy enhancer rapamycin(IH+RAPA) group, and intermittent low oxygen plus DBD-containing serum and the autophagy inhibitor 3-methyladenine(IH+DBD+3-MA) group. Monodansylcadaverine(MDC) staining was employed to detect the changes of autophagosomes. Cell counting kit-8(CCK-8) assay was employed to determine the activity of myocardial cells, and lactate dehydrogenase(LDH) and creatine kinase(CK) kits were used to measure the LDH and CK levels in the cell culture, which would reflect the degree of cell damage. TdT-mediated dUTP nick-end labeling(TUNEL) staining was used to detect the apoptosis of myocardial cells, and JC-1 fluorescence probe to detect the changes in mitochondrial membrane potential. Western blot was employed to determine the expression levels of the autophagy-related proteins microtubule-associated proteins light chain 3Ⅱ(LC3Ⅱ), microtubule-associated proteins light chain 3Ⅰ(LC3Ⅰ), P62, Parkin and apoptosis related proteins pro caspase-3, caspase-3, B-cell lymphoma-2(Bcl-2), Bcl-2-associated X(Bax). The results showed that compared with the CON group, the IH group showed decreased fluorescence intensity of MDC staining, decreased LC3Ⅱ/LC3Ⅰ ratio, down-regulated Parkin expression, and up-regulated expression of P62. In addition, the IH group showed decreased cell survival rate, increased content of LDH and CK in the culture medium, increased number of TUNEL positive cells, and decreased pro caspase-3/caspase-3 and Bcl-2/Bax ratios and mitochondrial membrane potential. Compared with the IH group, the IH+DBD and IH+RAPA groups showed increased fluorescence intensity of MDC staining, increased LC3Ⅱ/LC3Ⅰ ratio, up-regulated Parkin expression, and down-regulated P62 expression. In addition, the two groups showed increased cell survival rate, reduced content of LDH and CK in the culture medium, decreased number of TUNEL positive cells, and increased pro caspase-3/caspase-3 and Bcl-2/Bax ratios and mitochondrial membrane potential. The IH+DBD+3-MA and IH groups showed no significant differences in the above indicators. Compared with the IH+DBD group, the IH+DBD+3-MA group showed decreased fluorescence intensity of MDC staining, decreased LC3Ⅱ/LC3Ⅰ ratio, down-regulated Parkin expression, and up-regulated P62 expression. In addition, the group had decreased cell survival rate, increased content of LDH and CK in the culture medium, increased number of TUNEL positive cells, decreased pro caspase-3/caspase-3 and Bcl-2/Bax ratios, and declined mitochon-drial membrane potential. To sum up, DBD could promote the mitophagy, inhibit the apoptosis, and alleviated the injury of H9c2 cells exposed to low oxygen.
Oxygen
;
bcl-2-Associated X Protein/metabolism*
;
Caspase 3/genetics*
;
Proto-Oncogene Proteins c-bcl-2/metabolism*
;
Apoptosis
;
Autophagy
;
Ubiquitin-Protein Ligases
;
Microtubule-Associated Proteins
3.Mouse models of Mdm2 and Mdm4 and their clinical implications.
Chinese Journal of Cancer 2013;32(7):371-375
Mdm2 and Mdm4 are two key negative regulators of the tumor suppressor p53. Deletion of either Mdm2 or Mdm4 induces p53-dependent early embryonic lethality in knockout mouse models. The tissue-specific deletion of Mdm2 induces p53-dependent apoptosis, whereas the deletion of Mdm4 induces both p53-dependent apoptosis and cell cycle arrest. Compared to Mdm4 deletion, Mdm2 deletion causes more severe phenotypic defects. Disrupting the Mdm2 and Mdm4 interaction using knockin mice models causes embryonic lethality that can be completely rescued by the concomitant loss of p53, suggesting that Mdm2 and Mdm4 heterodimerization is critical to inhibit p53 activity during embryogenesis. Overexpression of Mdm2 and Mdm4 in mice induces spontaneous tumorigenesis, which clearly indicates that Mdm2 and Mdm4 are bona fide oncogenes. Studies from these mouse models strongly suggest that blocking Mdm2- and Mdm4-mediated p53 inhibition is an appealing therapeutic strategy for cancer patients with wild-type p53 alleles.
Animals
;
Apoptosis
;
Cell Cycle Checkpoints
;
Mice
;
Mice, Knockout
;
Models, Animal
;
Proto-Oncogene Proteins
;
genetics
;
metabolism
;
Proto-Oncogene Proteins c-mdm2
;
genetics
;
metabolism
;
Tumor Suppressor Protein p53
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Ubiquitin-Protein Ligases
;
genetics
;
metabolism
4.Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.
Limin HAN ; Pan WANG ; Ganye ZHAO ; Hui WANG ; Meng WANG ; Jun CHEN ; Tanjun TONG
Protein & Cell 2013;4(4):310-321
17β-estradiol (E2) treatment of cells results in an upregulation of SIRT1 and a down-regulation of PPARγ. The decrease in PPARγ expression is mediated by increased degradation of PPARγ. Here we report that PPARγ is ubiquitinated by HECT E3 ubiquitin ligase NEDD4-1 and degraded, along with PPARγ, in response to E2 stimulation. The PPARγ interacts with ubiquitin ligase NEDD4-1 through a conserved PPXY-WW binding motif. The WW3 domain in NEDD4-1 is critical for binding to PPARΓ. NEDD4-1 overexpression leads to PPARγ ubiquitination and reduced expression of PPARγ. Conversely, knockdown of NEDD4-1 by specific siRNAs abolishes PPARΓ ubiquitination. These data indicate that NEDD4-1 is the E3 ubiquitin ligase responsible for PPARγ ubiquitination. Here, we show that NEDD4-1 delays cellular senescence by degrading PPARΓ expression. Taken together, our data show that E2 could upregulate SIRT1 expression via promoting the PPARΓ ubiquitination-proteasome degradation pathway to delay the process of cell senescence.
Amino Acid Motifs
;
Animals
;
Cellular Senescence
;
Down-Regulation
;
drug effects
;
Endosomal Sorting Complexes Required for Transport
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Estradiol
;
pharmacology
;
Female
;
HeLa Cells
;
Humans
;
Mice
;
Mice, Inbred BALB C
;
Nedd4 Ubiquitin Protein Ligases
;
PPAR gamma
;
genetics
;
metabolism
;
Proteasome Endopeptidase Complex
;
metabolism
;
Protein Structure, Tertiary
;
RNA Interference
;
RNA, Small Interfering
;
metabolism
;
Sirtuin 1
;
genetics
;
metabolism
;
Ubiquitin
;
metabolism
;
Ubiquitin-Protein Ligases
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Ubiquitination
;
drug effects
;
Up-Regulation
;
drug effects
5.RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells.
Min WEI ; Yan-Ling ZHANG ; Lan CHEN ; Cui-Xia CAI ; Han-Duo WANG
Journal of Southern Medical University 2016;37(2):232-237
OBJECTIVETo explore the effects of silencing HERC4 on the proliferation, apoptosis, and migration of cervical cancer cell line Hela and the possible molecular mechanisms.
METHODSThree HERC4-specific small interfering RNAs (siRNAs) were transfected into Hela cells, and HERC4 expression in the cells was examined with Western blotting. CCK-8 assay, annexin V-FITC/PI assay, and wound healing assay were used to assess the effect of HERC4 silencing on the proliferation, apoptosis and migration ability of Hela cells. The expression levels of cyclin D1 and Bcl-2 in the cells were detected using Western blotting.
RESULTSTransfection of siRNA-3 resulted in significantly decreased HERC4 protein expression (P<0.01). HERC4 silencing by siRNA-3 markedly suppressed the proliferation and migration of Hela cells, increased the apoptosis rate (P<0.01) and reduced the expression levels of cyclin D1 and Bcl-2 (P<0.01).
CONCLUSIONSilencing of HERC4 efficiently inhibits the proliferation, migration, and invasion of Hela cells in vitro, and the underlying mechanisms may involve the down-regulation of cyclin D1 and Bcl-2.
Apoptosis ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Cyclin D1 ; metabolism ; Down-Regulation ; Female ; HeLa Cells ; Humans ; Proto-Oncogene Proteins c-bcl-2 ; metabolism ; RNA Interference ; RNA, Small Interfering ; genetics ; Transfection ; Ubiquitin-Protein Ligases ; genetics ; metabolism ; Uterine Cervical Neoplasms ; pathology
6.UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
Zi-Nan LU ; Jia SONG ; Tong-Hui SUN ; Gang SUN
Chinese Medical Journal 2021;134(20):2465-2474
BACKGROUND:
Ubiquitin-conjugating enzyme E2C (UBE2C) has been shown to be associated with the occurrence of various cancers and involved in many tumorigenic processes. This study aimed to investigate the specific molecular mechanism through which UBE2C affects breast cancer (BC) proliferation.
METHODS:
BC-related datasets were screened according to filter criteria in the Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas (TCGA) database. Then differentially expressed genes (DEGs) were identified using Venn diagram analysis. By using DEGs, we conducted the following analyses including Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interaction (PPI), and survival analysis, and then validated the function of the hub gene UBE2C using quantitative reverse transcription-polymerase chain reaction (RT-qPCR), cell counting kit-8 (CCK-8) assay, transwell assay, and Western blot assay.
RESULTS:
In total, 151 DEGs were identified from the GEO and TCGA databases. The results of GO analysis demonstrated that the DEGs were significantly enriched with mitotic nuclear division, lipid droplet, and organic acid-binding. KEGG analysis showed that the peroxisome proliferators-activated receptor (PPAR) signaling pathway, regulation of lipolysis in adipocytes, and proximal tubule bicarbonate reclamation were significantly enriched in the signal transduction pathway category. The top three hub genes that resulted from the PPI network were FOXM1, UBE2C, and CDKN3. The results of survival analysis showed a close relationship between UBE2C and BC. The results of CCK-8 and transwell assays suggested that the proliferation and invasion of UBE2C knockdown cells were significantly inhibited (P < 0.050). The results of Western blot assay showed that the level of phosphorylated phosphatase and tensin homology deleted on chromosome 10 (p-PTEN) was obviously increased (P < 0.050), whereas the levels of phosphorylated protein kinase B (p-AKT), phosphorylated mammalian target of rapamycin (p-mTOR), and hypoxia-inducible factor-1 alpha (HIF-1α) were dramatically decreased (P < 0.050) in the UBE2C knockdown cell.
CONCLUSION
UBE2C can promote BC proliferation by activating the AKT/mTOR signaling pathway.
Biomarkers, Tumor
;
Breast Neoplasms/pathology*
;
Cell Proliferation/genetics*
;
Computational Biology
;
Female
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Proto-Oncogene Proteins c-akt/genetics*
;
Signal Transduction/genetics*
;
TOR Serine-Threonine Kinases/genetics*
;
Ubiquitin-Conjugating Enzymes/metabolism*
7.Ubiquitination-mediated degradation of epidermal growth factor receptor.
Acta Academiae Medicinae Sinicae 2005;27(1):120-127
After binding to its ligand, epidermal growth factor receptor (EGFR) dimerizes and is autophosphorylated. These events initiate the signal transduction process, which regulates a plethora of biologic activity. The duration and strength of these signals are controlled by many regulatory mechanisms, including downregulating activated EGFR primarily via endocytosis and ubiquitination-dependent lysomal degradation. The interaction between EGFR and the ubiquitin ligase Cbl/adaptor protein CIN85, as well as ESCRT complex recruitment play important roles in the process of downregulating EGFR. Tumorigenesis results when the de-sensitization process of EGFR is halted by its own mutation or a mutation that abrogates Cbl E3 ligase activity.
Adaptor Proteins, Signal Transducing
;
metabolism
;
Animals
;
Down-Regulation
;
Endocytosis
;
Epidermal Growth Factor
;
pharmacology
;
Humans
;
Mutation
;
Proto-Oncogene Proteins c-cbl
;
metabolism
;
Receptor, Epidermal Growth Factor
;
genetics
;
metabolism
;
Signal Transduction
;
Ubiquitin
;
metabolism
8.Effect of TRIM31 Gene Silencing on the Proliferation and Apoptosis of U266 Cells and Its Mechanism.
Xing-Xing LONG ; Feng WEN ; Qian CHEN ; Yi-Xiong CAO ; Xiao-Qing HUANG
Journal of Experimental Hematology 2021;29(3):805-811
OBJECTIVE:
To investigate the effect of the tripartite motif containing 31 (TRIM31) gene silencing on the proliferation and apoptosis of multiple myeloma cells and its possible mechanism.
METHODS:
The normal bone marrow plasma cells (nPCs) were selected as control, and the mRNA and protein expression levels of TRIM31 in human multiple myeloma cell lines (U266, RPMI-8226, NCI-H929 and KMS-11) were detected by RT-qPCR and Western blot. Recombinant lentivirol vector containing shRNA-TRIM31 and its negative control were used to infect U266 cells respectively, and the mRNA expression level of TRIM31 in infected cells was detected by RT-qPCR. Then cell proliferation, colony forming and apoptosis were analyzed by CCK-8, soft agar assay, and flow cytometry, respectively. The protein expression levels of TRIM31, cleaved-caspase-3, BCL-2, Bax, p-Akt (Ser473), Akt and PI3K (p110α) were evaluated by Western blot. In addition, the PI3K/Akt signaling pathway-specific inhibitor LY294002 and TRIM31-shRNA lentivirus were used to interfere with U266 cells, and the cell proliferation, apoptosis, and protein expression of p-Akt (Ser473) and Akt were detected by CCK-8, flow cytometry and Western blot, respectively.
RESULTS:
Compared with nPCs, the expression levels of TRIM31 mRNA and protein in U266, RPMI-8226, NCI-H929 and KMS-11 cells were significantly increased (P<0.001), especially in U266 cells. After lentivirus infection, the levels of TRIM31 mRNA and protein in U266 cells were significantly decreased (P<0.001). TRIM31 silencing significantly inhibited the proliferation of U266 cells (P<0.05), attenuated the ability of cell cloning, improved cell apoptosis, up-regulated the protein expressions of cleaved-caspase-3 and Bas as well as down-regulated expressions of BCL-2, p-Akt (Ser473) and PI3K (p110α). There was no significant effect on Akt protein. Intervention of LY294002 significantly enhanced the inhibition on cell proliferation and the promotion on apoptosis mediated by TRIM31 gene silencing in U266 cells.
CONCLUSION
TRIM31 gene silencing can inhibit U266 cell proliferation and promote its apoptosis, which may be closely related to inhibition of PI3K/Akt signaling pathway.
Apoptosis
;
Cell Line, Tumor
;
Cell Proliferation
;
Gene Silencing
;
Humans
;
Multiple Myeloma
;
Phosphatidylinositol 3-Kinases/metabolism*
;
Proto-Oncogene Proteins c-akt/metabolism*
;
Tripartite Motif Proteins/genetics*
;
Ubiquitin-Protein Ligases/genetics*
9.Phosphorylation of Rictor at Thr1135 impairs the Rictor/Cullin-1 complex to ubiquitinate SGK1.
Daming GAO ; Lixin WAN ; Wenyi WEI
Protein & Cell 2010;1(10):881-885
The Rictor/mTOR complex plays a pivotal role in a variety of cellular functions including cellular metabolism, cell proliferation and survival by phosphorylating Akt at Ser473 to fully activate the Akt kinase. However, its upstream regulatory pathways as well as whether it has additional function(s) remain largely unknown. We recently reported that Rictor contains a novel ubiquitin E3 ligase activity by forming a novel complex with Cullin-1, but not with other Cullin family members. Furthermore, we identified SGK1 as its downstream target. Interestingly, Rictor, but not Raptor or mTOR, promotes SGK1 ubiquitination. As a result, SGK1 expression is elevated in Rictor(-/-) MEFs. We further defined that as a feedback mechanism, Rictor can be phosphorylated by multiple AGC family kinases including Akt, S6K and SGK1. Phosphorylation of Rictor at the Thr1135 site did not affect its kinase activity towards phosphorylating its conventional substrates including Akt and SGK1. On the other hand, it disrupted the interaction between Rictor and Cullin-1. Consequently, T1135E Rictor was defective in promoting SGK1 ubiquitination and destruction. This finding further expands our knowledge of Rictor's function. Furthermore, our work also illustrates that Rictor E3 ligase activity could be governed by specific signaling kinase cascades, and that misregulation of this process might contribute to SGK overexpression which is frequently observed in various types of cancers.
Animals
;
Carrier Proteins
;
metabolism
;
Cell Proliferation
;
Cells, Cultured
;
Cullin Proteins
;
genetics
;
metabolism
;
Fibroblasts
;
metabolism
;
Humans
;
Immediate-Early Proteins
;
metabolism
;
Mice
;
Phosphorylation
;
Protein-Serine-Threonine Kinases
;
genetics
;
metabolism
;
Proto-Oncogene Proteins c-akt
;
genetics
;
metabolism
;
Rapamycin-Insensitive Companion of mTOR Protein
;
TOR Serine-Threonine Kinases
;
genetics
;
metabolism
;
Ubiquitin
;
genetics
;
metabolism
;
Ubiquitination
10.Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis.
Hui-jie HUANG ; Fang ZHENG ; Fang-ping XU ; Yan-hui LIU ; Heng-guo ZHUANG
Chinese Journal of Pathology 2013;42(3):214-216
Animals
;
Carcinogenesis
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
Cyclin E
;
metabolism
;
F-Box Proteins
;
genetics
;
metabolism
;
F-Box-WD Repeat-Containing Protein 7
;
Gene Silencing
;
Genes, Tumor Suppressor
;
Humans
;
Mutation
;
Myeloid Cell Leukemia Sequence 1 Protein
;
metabolism
;
Neoplasms
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-myc
;
metabolism
;
Receptors, Notch
;
metabolism
;
Signal Transduction
;
TOR Serine-Threonine Kinases
;
metabolism
;
Ubiquitin-Protein Ligases
;
genetics
;
metabolism